SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Front view of the White House
IRA
White House Expects IRA’s Negotiated Drug Prices to Save Medicare $6B in 2026
The Biden administration on Thursday announced that the Inflation Reduction Act’s Medicare Drug Price Negotiation Program will save the U.S. government around $6 billion in its first year of implementation.
August 15, 2024
 · 
3 min read
 · 
Tristan Manalac
Professional with packed box
Layoffs
Layoff Dilemma: Would You Take Pay Cut, Demotion to Keep Your Job?
To avoid being laid off, a third of biopharma professionals would take a pay cut and nearly a quarter would take a demotion, according to BioSpace LinkedIn polls. We spoke to several professionals about their layoff experiences and what they would—and wouldn’t—have done to keep their jobs.
August 15, 2024
 · 
6 min read
 · 
Angela Gabriel
Group of employees being laid off by their company
Layoffs
Grail Lays Off About 350 Employees, Puts Brakes on New Hires
The layoffs will help extend the company’s cash runway from the second half of 2026 into 2028.
August 14, 2024
 · 
1 min read
 · 
Angela Gabriel
Pills and cash
IRA
Experts Analyze IRA’s Effect as the Industry Awaits Negotiated CMS Drug Prices
The new Medicare prices for the first 10 drugs negotiated under the Inflation Reduction Act are expected soon. Analysts and researchers are divided on the long-term effects of the law.
August 14, 2024
 · 
6 min read
 · 
Tyler Patchen
Facade of AstraZeneca's office in Shanghai, China
Approvals
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer
The European Union has approved the first-ever combination therapy consisting of an immunotherapy and a PARP inhibitor for the treatment of endometrial cancer, AstraZeneca announced Wednesday.
August 14, 2024
 · 
2 min read
 · 
Tristan Manalac
A piggy bank crammed with $100 bills on a background of American cash
Business
Biotech Industry Overcomes Slump, Adapts to New Normal
M&A activity surges and IPOs return as the biotech industry navigates a changing business landscape marked by strategic consolidation and renewed investor focus on innovation.
August 14, 2024
 · 
6 min read
 · 
Ana Mulero
a robotic assembly line with vials
Opinion
Invest in Domestic Manufacturing to Onshore America’s Biotech Supply Chain
As the U.S. moves away from reliance on Chinese CDMOs, Southern cities provide a model for how we can bolster domestic production capacity.
August 14, 2024
 · 
5 min read
 · 
Josh Carpenter
Illumina's signage at its headquarters in San Diego, California
Business
Illumina Lays Out Growth Roadmap After Grail Divestment
In a bid to win back investor confidence, Illumina on Tuesday unveiled a three-year growth plan focused on easier DNA sequencing and improved data analysis for customers.
August 14, 2024
 · 
2 min read
 · 
Tristan Manalac
Lilly's newly opened Seaport Center in Boston
Gene therapy
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
August 14, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS